Retinal vascular signs as risk markers for incident stroke or cerebrovascular death: A population-based assessment
视网膜血管体征作为中风或脑血管死亡风险标记:基于人群的评估
基本信息
- 批准号:nhmrc : 153948
- 负责人:
- 金额:$ 27.35万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Project Grants
- 财政年份:2001
- 资助国家:澳大利亚
- 起止时间:2001-01-01 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Stroke remains a major cause of disability and death in Australia. Preliminary data from the Blue Mountains Eye Study suggest that blood vessel changes observed in the retina at the back of the eye may provide signs of an increased risk of stroke or death from stroke. Importantly, although stroke is strongly associated with elevated blood pressure, the risk associated with these blood vessel signs seems to be independent of blood pressure. The proposed study will conduct a detailed re-grading of retinal photographs taken on people who attended the Eye Study during 1992-4 and 5-year follow-up exams during 1997-9. We will grade these photographs manually (using a stereo-viewer), and with computer assistance to measure changes in the diameter of small arteries in the retina and other signs. By closely matching our grading technique to that used in a large American Study, we hope to develop reliable grading for these signs and will be able to compare our findings internationally. Our aim is to assess the frequency of abnormal retinal vessel changes in people of different age groups as well as the development and progression of these signs over time. Their relationship to well known vascular risk factors like smoking, blood pressure, obesity, diabetes and cholesterol will also be investigated. We hope to be able to discriminate those changes associated with an increased stroke risk from those due to normal ageing. We expect that the increased stroke risk associated with abnormal retinal vessel changes may be greater than shown in our early data. If confirmed, then these findings may provide a more sensitive and objective measure of stroke risk than relying on traditional risk factors, which are difficult to quantify and change with time. We may be able to develop simple rules so that doctors using an ophthalmoscope or examining a retinal photograph could identify high risk patients. These people could benefit from interventions to reduce their risk.
中风仍然是澳大利亚残疾和死亡的主要原因。来自蓝山眼科研究的初步数据表明,在眼睛后部视网膜中观察到的血管变化可能提供中风或中风死亡风险增加的迹象。重要的是,虽然中风与血压升高密切相关,但与这些血管体征相关的风险似乎与血压无关。这项拟议的研究将对参加1992- 1997- 1999年4年和5年随访检查的人的视网膜照片进行详细的重新分级。我们将对这些照片进行手动分级(使用立体观察器),并在计算机辅助下测量视网膜小动脉直径和其他体征的变化。通过将我们的分级技术与美国一项大型研究中使用的技术紧密匹配,我们希望为这些体征制定可靠的分级,并将能够在国际上比较我们的研究结果。我们的目的是评估不同年龄组人群中异常视网膜血管变化的频率以及这些体征随时间的发展和进展。他们与众所周知的血管危险因素,如吸烟,血压,肥胖,糖尿病和胆固醇的关系也将被调查。我们希望能够区分那些与中风风险增加相关的变化与正常衰老相关的变化。我们预计,与视网膜血管异常改变相关的中风风险增加可能比我们早期数据显示的更大。如果得到证实,那么这些发现可能会提供比依赖传统风险因素更敏感和客观的中风风险衡量标准,传统风险因素难以量化并随时间变化。我们也许能够制定简单的规则,以便医生使用检眼镜或检查视网膜照片可以识别高风险患者。这些人可以从干预措施中受益,以降低他们的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prof Jie Jin Wang其他文献
Prof Jie Jin Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prof Jie Jin Wang', 18)}}的其他基金
Genes and Environment in the Risk of Early Age-Related Macular Degeneration: A Population-based Case-Control Study
早期年龄相关性黄斑变性风险中的基因和环境:基于人群的病例对照研究
- 批准号:
nhmrc : 512423 - 财政年份:2008
- 资助金额:
$ 27.35万 - 项目类别:
NHMRC Project Grants
Research Fellowship - Grant ID:358702
研究奖学金 - 拨款 ID:358702
- 批准号:
nhmrc : 358702 - 财政年份:2005
- 资助金额:
$ 27.35万 - 项目类别:
NHMRC Research Fellowships
Retinal vascular signs as predictors of systemic disease outcomes: 10-year evolution in a population-based cohort
视网膜血管体征作为全身疾病结果的预测因子:基于人群的队列的 10 年演变
- 批准号:
nhmrc : 302068 - 财政年份:2004
- 资助金额:
$ 27.35万 - 项目类别:
NHMRC Project Grants
Incidence and progression of Age-related Maculopathy in a population-based cohort
基于人群的队列中年龄相关性黄斑病的发病率和进展
- 批准号:
nhmrc : 987445 - 财政年份:1998
- 资助金额:
$ 27.35万 - 项目类别:
NHMRC Postgraduate Scholarships
相似国自然基金
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
- 批准号:82371605
- 批准年份:2023
- 资助金额:46.00 万元
- 项目类别:面上项目
尾加压素II介导血管外膜氧化应激促进血管重构的作用研究
- 批准号:81141003
- 批准年份:2011
- 资助金额:10.0 万元
- 项目类别:专项基金项目
核素靶向示踪肿瘤新生血管作用位点研究
- 批准号:81071183
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
硫化氢通过核转录因子-kB信号途径调节高血压大鼠血管平滑肌细胞增殖的研究
- 批准号:81070212
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
内源性硫化氢调控高血压血管基质重塑的研究
- 批准号:30801251
- 批准年份:2008
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
尾加压素II在血管重构中对外膜的作用及机制研究
- 批准号:30871066
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
电场对血管发生的调控作用及其信号转导通路的研究
- 批准号:30871268
- 批准年份:2008
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Bioenergetic impairment in Group 3 pulmonary hypertension
第 3 组肺动脉高压的生物能损伤
- 批准号:
10740337 - 财政年份:2023
- 资助金额:
$ 27.35万 - 项目类别:
Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures
芥子气引起的结膜损伤的机制以及脂质介质作为医疗对策的使用
- 批准号:
10882060 - 财政年份:2023
- 资助金额:
$ 27.35万 - 项目类别:
Cognitive sequelae of cerebrovascular and gut dysfunction in post-acute COVID-19 syndrome.
急性后 COVID-19 综合征脑血管和肠道功能障碍的认知后遗症。
- 批准号:
10627220 - 财政年份:2023
- 资助金额:
$ 27.35万 - 项目类别:
Placental Organoids for Modeling and Treating Preeclampsia
用于建模和治疗先兆子痫的胎盘类器官
- 批准号:
10464766 - 财政年份:2022
- 资助金额:
$ 27.35万 - 项目类别:
Targeting mitochondria-derived reactive oxygen species as a therapy for combined pre- and post-capillary pulmonary hypertension
靶向线粒体衍生的活性氧作为治疗毛细血管前和后联合肺动脉高压的方法
- 批准号:
10535666 - 财政年份:2022
- 资助金额:
$ 27.35万 - 项目类别:
Deep Phenotypic Characterization of Prodromal Dementia with Lewy Bodies
路易体前驱痴呆的深层表型特征
- 批准号:
10670501 - 财政年份:2022
- 资助金额:
$ 27.35万 - 项目类别:
The role of endothelial derived Leucine-Rich Alpha-2-Glycoprotein 1 (LRG1) in the pathogenesis of COPD
内皮源性富含亮氨酸的 Alpha-2-糖蛋白 1 (LRG1) 在 COPD 发病机制中的作用
- 批准号:
10507591 - 财政年份:2022
- 资助金额:
$ 27.35万 - 项目类别: